Infants are more vulnerable than older children to severe illness from viruses like the flu and RSV, and symptoms can include vomiting and diarrhea for roughly one-third of kids.
Both immunizations are highly effective at keeping kids and babies healthy.
Newborns immunized against RSV also had a 36% lower risk of infection with a life-threatening illness called invasive pneumococcal disease.
A Mayo Clinic study finds the risk is almost doubled for adults under 50, a group currently not broadly advised to get an RSV vaccine.
The reduction in transfers to emergency departments is driven by increased testing and case detection and faster flu antiviral initiation rather than smaller outbreaks.
A study of women in 8 countries finds that they often agree to RSV vaccination during pregnancy and believe it’s better than immunizing their babies directly.
A new study finds that benefits of mRNA technology are substantial and serious adverse events rare.
For well over a year, public health experts have been planning how to protect fans from infectious diseases such as flu, COVID, and measles (part 1 of 2).
The guidance illustrates the growing chasm between the medical organization and the federal health agency.
Study finds that when moms get vaccinated for respiratory syncytial virus while pregnant, RSV hospitalizations for babies decrease by 70%.
